Ethadox is addressing the growing and unmet need of treating diseases and conditions associated with high level of acetaldehyde (AcH)/alcohol.
AcH, from internal or external source, is a neurotoxic and carcinogenic substance. Ethadox’s drug-device will significantly reduce peripheral and cerebral blood AcH concentration. In the first instance, Ethadox will concentrate on Parkinson’s Disease.